Nov 18O0.96H1.07L0.92C1.03Vol765.0k
Inmune Bio Inc stock is traded at $1.03, with a volume of 765,043. It is up +7.29% in the last 24 hours and down -34.39% over the past month. INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Previous Close:
$0.96
Open:
$0.9608
24h Volume:
765,043
Relative Volume:
1.49
Market Cap:
$31.89M
Revenue:
$50,000
Net Income/Loss:
-$41.60M
P/E Ratio:
-
EPS:
-$1.69
Net Cash Flow:
-$20.20M
1W Performance:
-6.36%
1M Performance:
-34.39%
6M Performance:
-30.87%
1Y Performance:
-31.33%
1-Day Range:
$0.9236$1.07
1-Week Range:
$0.8933$1.10
52-Week Range:
$0.8933$2.60
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 964-3720Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS